Biopharma Business

Tag "FDA Approval"

FDA approves Bydureon BCise for patients with type-2 diabetes

    FDA approves Bydureon BCise for patients with type-2 diabetes

The FDA has approved Bydureon BCise for adults with type-2 diabetes whose blood sugar remains uncontrolled on one or more oral medicines. AstraZeneca has announced that the US Food and Drug Administration

Read Full Article

Cork-based AventaMed eyes FDA approval after raising €1.8m

    Cork-based AventaMed eyes FDA approval after raising €1.8m

AventaMed, a Cork-based medtech firm focused on simplifying surgical procedures, has secured a €1.8 million investment to enable the company to attain FDA approval and go to market in the

Read Full Article

FDA accepts regulatory submission for Lynparza in metastatic breast cancer

    FDA accepts regulatory submission for Lynparza in metastatic breast cancer

Lynparza has the potential to offer a new treatment option for patients with metastatic breast cancer. AstraZeneca and Merck & Co., have announced that the US Food and Drug Administration

Read Full Article

Janssen announces FDA approval of Stelara for plaque psoriasis

    Janssen announces FDA approval of Stelara for plaque psoriasis

The FDA has approved an expanded indication for Stelara for the treatment of adolescents with moderate plaque psoriasis. Janssen Biotech, Inc., has announced that the U.S. Food and Drug Administration

Read Full Article

Alcohol aversion drug Disulfiram may combat chemotherapy resistance

    Alcohol aversion drug Disulfiram may combat chemotherapy resistance

Scientists have had positive results from a laboratory-based study using a well-known alcohol aversion drug disulfiram, to combat chemotherapy resistance in the most common type of lung cancer, non-small cell

Read Full Article

A New Parkinson’s Drug from Italy just got FDA Approval!

Newron, an Italian biotech focused on CNS diseases, is on a roll. The latest win? FDA approval of its Parkinson’s drug, Xadago. Just in time for World Parkinson’s Day on

Read Full Article

British Biotech’s Breast Cancer Drug gets FDA Approval for Novartis

Novartis has received FDA approval for Kisqali, a first-line treatment for breast cancer originally developed by the British biotech Astex Pharmaceuticals. The oncology company Astex Pharmaceuticals, located in Cambridge’s biotech hub, entered

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements